Aug 25, 2020   SOURCE: PR NewsWire

Global Diabetes Diagnostic & Monitoring Markets Executive and Consultant Guides 2020

DUBLIN, Aug. 25, 2020 /PRNewswire/ -- The "Diabetes Diagnostic & Monitoring Markets with Executive and Consultant Guides - Including Customized Forecasting and Analysis 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Will diabetes management become a diabetes cure? Diabetes management is moving onto phones and laptops and integrated into physicians' databases. Well established players are jockeying for position in this emerging digital environment while the fundamentals suggest global growth that will continue well into the future. The results of these efforts will change what diabetes means to millions of people worldwide. The digital revolution is breathing new life into the commodity world of testing strips. Understand what is driving this huge global diagnostic market.

The report forecasts the market size out to 2024. Growth is coming from the fundamentals and the move to the real-time data management of blood parameters. When does effective management constitute a cure? New technologies are bringing an artificial pancreas into view. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Digital Diagnostics are merging with spectacular success.

Key Topics Covered:

1. Introduction and Market Definition
1.1 An Overview of Diagnostics and Monitoring of Diabetes
1.2 Diabetes Prevalence - the Big Picture
1.3 Market Definition
1.4 Methodology
1.5 U.S. Medical Market and laboratory Testing - Perspective

2. Diabetes - Current Science
2.0 Understanding the Disease
2.1 Type 1
2.2 Type 2
2.3 Diabetes Related Disease
2.4 Pancreas and Autoimmunity

3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Pharmaceutical/Reagent Supplier
3.1.4 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Lab
3.1.9 Audit Body
3.1.10 Certification Body

4. Market Trends
4.1 Factors Driving Growth
4.2 Factors Limiting Growth
4.3 Diagnostic Technology Development

5. Diabetes Diagnostics - Recent Developments

    --  Diabetes app Glucose Buddy supports Dexcom CGM devices
    --  Abbott's Freestyle Libre 2 Secures CE Mark
    --  Siemens Healthineers and Hill-Rom to Provide Comprehensive Diabetes Care
    --  Trividia Health, Inc. to acquire Freedom Meditech
    --  Medtronic to Acquire Nutrino Health
    --  Nova Biomedical Receives FDA Clearance for Capillary Testing with
        Critically Ill Patients
    --  ARKRAY announces new blood glucose monitoring systems
    --  Life365 Extends Connected Care Platform Partnership with OSANG
        Healthcare
    --  AgaMatrix Enters Strategic Partnership with Arcadia Group
    --  PTS Diagnostics Updated System, Lowers Average Cost Per Test
    --  ACON Laboratories Launches New System for the Veterinary Market
    --  Senseonics extends distribution agreement with Roche Diabetes Care
    --  Ascensia Diabetes Care Announces Global Partnership with Poctech
    --  New Release of OneTouch Reveal Mobile App
    --  J&J to sell Lifescan, dropping out of diabetes diagnostics

6. Profiles of Key Companies

    --  A.Menarini Diagnostics Ltd.
    --  Acon Laboratories, Inc.
    --  AgaMatrix, Inc.
    --  Agilent (Dako)
    --  Apex Biotechnology Corporation
    --  ARKRAY, Inc.
    --  Ascensia Diabetes Care Holdings AG
    --  B. Braun Melsungen AG
    --  Becton, Dickinson & Co
    --  Beckman Coulter, Inc.
    --  BIONIME Corporation
    --  Bio-Rad Laboratories
    --  Danaher Corporation
    --  DexCom, Inc.
    --  Diazyme Laboratories Inc.
    --  EKF Diagnostics Holdings Plc
    --  HemoCue AB
    --  LifeScan, Inc.
    --  Medtronic PLC
    --  Nipro Europe
    --  Nova Biomedical Corporation
    --  OSANG Healthcare Co., Ltd.
    --  Pepex Biomedical
    --  PTS Diagnostics
    --  Roche Diabetes Care, Inc.
    --  Sanofi S.A.
    --  Sanwa Kagaku Kenkyusho Co, Ltd.
    --  Siemens Healthineers
    --  Sinocare, Inc.
    --  Trividia Health, Inc
    --  TaiDoc Technology Corporation
    --  Tandem Diabetes Care, Inc
    --  Terumo Corporation
    --  Thermo Fisher Scientific
    --  Tosoh Bioscience, Inc.
    --  Trinity Biotech plc
    --  Ypsomed AG

7. Diabetes Diagnostic Markets

8. Global Diabetes Diagnostics Markets - By Assay

9. Appendices

For more information about this report visit https://www.researchandmarkets.com/r/whadph

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-diabetes-diagnostic--monitoring-markets-executive-and-consultant-guides-2020-301117750.html

SOURCE Research and Markets